Skip to main content
An official website of the United States government

Serological Sciences Centers of Excellence

As part of the NCI Serological Sciences Network (SeroNet), NCI has awarded eight institutions U54 grants to conduct multiple research projects to characterize the immune responses to coronavirus infection and learn about what drives immune response, disease progression, and protection against future infection.

Awarded Centers of Excellence
Center Description Principal Investigator(s)/Institution
Center for Serological Testing to Improve Outcomes from Pandemic COVID-19 (STOP-COVID) Conduct longitudinal serologic tracking of individuals exposed to SARS-CoV-2, perform molecular analysis of their immune response, and to create communication tools for targeted populations Eugene M. Oltz,
Ann Scheck McAlearney, Ashish Raman Panchal, Linda J. Saif

Ohio State University
North Carolina SeroNet Center for Excellence Perform studies that advance understanding of the serologic response to SARS-CoV-2 and its role in protective immunity though fundamental characterizations of natural infections, therapeutic interventions, and vaccines Ralph S. Baric,
Shannon Margaret Wallet

UNC-Chapel Hill
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 Examine the correlation of COVID-19 disease trajectories with several demographic factors and to study the effect of metabolic disorders, blood cancers, and cancer immunotherapy on the disease pathology Susan Cheng,
Jane C. Figueirdo,
Michael Karin

Cedars-Sinai Medical Center
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS) Evaluate the innate and adaptive immune responses to SARS-CoV-2 in patients sampled longitudinally in order to distinguish immune responses that are protective from those that cause disease complications Sabra L. Klein,
Andrea L. Cox

Johns Hopkins University
Tulane University COVID Antibody and Immunity Network (TUCAIN) Characterize the antibody profiles in diverse populations of SARS-CoV-2 infected individuals including cancer patients; perform longitudinal studies of antibody specificity and function from COVID-19 survivors; and study how other seasonal coronaviruses shape immunity and clinical course of infection of the novel SARS-CoV-2 James E. Robinson

Tulane University
Mechanisms and Duration of Immunity to SARS-CoV-2 Study the molecular mechanisms of the adaptive immune response in COVID-19 patients, including those with cancer and the medically underserved Scott Dexter Boyd

Stanford University
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity Investigate immunological mechanisms underlying the course of COVID-19 infection in cancer patients and patients with autoimmune disease Ignacio E. Sanz,
Madhav V. Dhodapkar

Emory University
Vulnerability of SARS-CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses Gain insights into why patients with lung cancer show much higher susceptibility to mortality due to SARS-CoV-2 infection Fred R. Hirsch,
Adolfo Garcia-Sastre

Icahn School of Medicine at Mount Sinai
  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Serological Sciences Centers of Excellence was originally published by the National Cancer Institute.”